Ortho Clinical Diagnostics Holdings plc (OCDX)

NASDAQ: OCDX · IEX Real-Time Price · USD
17.55
-0.18 (-1.02%)
May 25, 2022 4:00 PM EDT - Market closed

Company Description

Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide.

The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases.

The company is also involved in the provision of contract manufacturing and orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers.

Ortho Clinical Diagnostics Holdings plc was founded in 1939 and is headquartered in Raritan, New Jersey.

Ortho Clinical Diagnostics Holdings plc
CountryUnited States
Founded1939
IPO DateJan 28, 2021
IndustryHealth Care Equipment & Supplies
SectorHealth Care
Employees4,800

Contact Details

Address:
1001 Route 202
Raritan, NJ 08869
United States
Phone908 218 8000
Websiteorthoclinicaldiagnostics.com

Stock Details

Ticker SymbolOCDX
ExchangeNASDAQ
Fiscal YearFebruary - January
Reporting CurrencyUS Dollars
IPO Price$17.00
CIK Code1828443

Key Executives

NamePosition
Christopher Michael SmithChairman and Chief Executive Officer
Joseph M. Busky CPAChief Financial Officer
Michael A. SchlesingerExecutive Vice President, General Counsel and Secretary
Michael S. IskraExecutive Vice President of Commercial Excellence and Strategy
Dr. Chockalingam Palaniappan Ph.D.Chief Innovation Officer
Ariane SchiereckChief Information Officer
Marwan FathallahHead of Quality, Regulatory, Compliance, Clinical, Medical and Scientific Affairs
Gary PassmanHead of People and Culture
Karen TaylorHead of Global Commercial Enablement
Warren StoneHead of Americas

Latest SEC Filings

DateTypeTitle
May 20, 20228-KCurrent report
May 20, 20228-K/ACurrent report
May 19, 20228-K/ACurrent report
May 18, 20228-KCurrent report
May 16, 20228-KCurrent report
May 9, 202210-QQuarterly report [Sections 13 or 15(d)]
May 6, 2022425Prospectuses and communications, business combinations
May 6, 20228-KCurrent report
May 4, 2022425Prospectuses and communications, business combinations
May 4, 2022425Prospectuses and communications, business combinations
View All SEC Filings